An MMP13-Selective Inhibitor Delays Primary Tumor Growth and the Onset of Tumor-Associated Osteolytic Lesions in Experimental Models of Breast Cancer
Figure 9
Expression of Ki67 in the experimental mice tumors from syngeneic (top panel) and xenograft (bottom panel) models treated with either vehicle, low and high dose of Cmpd-1.